Construction Cost Simulation Based on Artificial Intelligence and BIM

Quickly estimating the main engineering quantity and project cost of the project is conducive to the management staff to have an overall grasp of the project in the early stage and to grasp the development direction of the project in advance. Moreover, it can play an important guiding role in the further construction management of the project and can help managers prevent the emergence of unfavorable factors in the project, make corresponding construction deployments, and avoid risks. This paper combines artificial intelligence technology to construct a construction project cost simulation system. In this system, BIM is mainly used to simulate construction engineering, and the construction engineering cost is simulated and analyzed in combination with the pricing file. Finally, the results of experimental research show that the intelligent model proposed in this paper can play an important role in the cost of construction projects.

Price versus clinical guidelines in primary care statin prescribing: a retrospective cohort study and cost simulation model

Objective To investigate the relative impact of generic entry and National Institute for Health and Care Excellence clinical guidelines on prescribing using statins as an exemplar. Design Retrospective analysis of statin prescribing in primary care and cost simulation model. Setting Royal College of General Practitioners Research and Surveillance Centre (RCGP R&SC) database and Prescription Cost Analysis (PCA) database. Participants New patients prescribed statins for the first time between July 2003 and September 2018. Results General trends of statin’ prescriptions were largely driven by a decrease in acquisition costs triggered by patent expiration, preceding NICE guidelines which themselves did not seem to affect prescription trends. Significant heterogeneity is observed in the prescription of the most cost-effective statin across GPs. A cost simulation shows that, between 2004 and 2018, the NHS could have saved £2.8bn (around 40% of the £6.3bn spent on statins during this time) if all GP practices had prescribed only the most cost-effective treatment. Conclusions There is potential for large savings for the NHS if new and, whenever possible, ongoing patients are promptly switched to the first medicine that becomes available as generic within a therapeutic class as long as it has similar efficacy to still-patented medicines.

A Low-cost model of breast biopsy for the training of surgical residents during COVID-19 pandemic

We describe a low-cost simulation model for teaching core needle biopsy to surgical trainees in Low- and Middle-income countries (LMICs). Pre-session and post-session surveys showed that correct core sampling (ability to hit the beetroot) after training was 91.4% compared to 75.7% before demonstration and improved adequacy (68.5% before v. 85.7% after). This low-cost model using locally available products is designed to simulate a palpable breast lump and can easily be incorporated into surgical training in LMICs, where a palpable breast lump is the commonest presentation of breast cancer.